How many institutions held PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in Q2 2023?

46 institutional investors reported PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Q: What does CUSIP 747324101 represent in this 13F holders report?

CUSIP 747324101 is the security identifier for PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 747324101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 62,130,557
Total 13F shares: 9,605,170
Share change: -749,829
Total reported value: $24,586,580
Price per share: $2.56
Number of holders: 46
Value change: -$3,344,692
Number of buys: 34
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 747324101?
CUSIP 747324101 identifies PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 747324101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PFIZER INC	3/4/5	10%+ Owner	— class O/S missing	7,032,770	$19,410,445	—	17 Mar 2023	3/4/5
Laurion Capital Management LP	13F	Company	5.1%	3,170,803	$12,714,920	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	4%	2,481,662	$9,951,465	—	31 Mar 2023	13F
BARCLAYS PLC	3/4/5 13F	10%+ Owner · Company	0.19% from 13F	3,477,975	$4,869,165	—	26 Apr 2022	3/4/5 13F
VANGUARD GROUP INC	13F	Company	1.7%	1,062,549	$4,260,821	—	31 Mar 2023	13F
Bayer World Investments B.V.	3/4/5	Former 10% Owner	— class O/S missing	2,742,338	$3,839,273	—	13 Oct 2021	3/4/5
Tekla Capital Management LLC	13F	Company	1.1%	708,303	$2,840,295	—	31 Mar 2023	13F
HHLR ADVISORS, LTD.	13F	Company	0.85%	530,692	$2,128,075	—	31 Mar 2023	13F
Cormorant Asset Management, LP	3/4/5 13F	Former 10% Owner · Company	0.44% from 13F	1,118,854	$1,566,396	—	13 Oct 2021	3/4/5 13F
Jay Feingold	3/4/5	Chief Medical Officer	— mixed-class rows	747,862 mixed-class rows	$1,089,573	—	24 Mar 2023	3/4/5
Point72 Asset Management, L.P.	13F	Company	0.41%	251,800	$1,009,718	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.39%	239,351	$959,797	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.34%	212,288	$851,275	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	170,295	$682,883	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.27%	168,576	$675,990	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.15%	94,200	$378,000	—	31 Mar 2023	13F
Harvest Investment Services, LLC	13F	Company	0.15%	91,047	$365,098	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.12%	75,430	$302,474	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.12%	72,545	$291,000	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.11%	70,000	$281,000	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.11%	69,782	$279,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.1%	62,289	$249,779	—	31 Mar 2023	13F
Ronald Herbst	3/4/5	Chief Scientific Officer	— mixed-class rows	118,674 mixed-class rows	$234,796	—	07 Oct 2021	3/4/5
UNIVERSITY OF CHICAGO	13F	Company	0.08%	48,731	$195,411	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.06%	37,945	$152,159	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	35,424	$142,050	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.05%	32,506	$130,000	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.05%	31,507	$126,343	—	31 Mar 2023	13F
Ritu Shah	3/4/5	Chief Operating Officer	— class O/S missing	31,344	$120,048	—	07 Oct 2021	3/4/5
CITADEL ADVISORS LLC	13F	Company	0.04%	27,129	$108,787	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	25,000	$100,250	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	23,492	$94,202	—	31 Mar 2023	13F
Kingsview Wealth Management, LLC	13F	Company	0.03%	20,000	$80,200	—	31 Mar 2023	13F
Bleakley Financial Group, LLC	13F	Company	0.03%	18,110	$72,621	—	31 Mar 2023	13F
Simplicity Solutions, LLC	13F	Company	0.03%	18,110	$72,621	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	17,739	$71,133	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.02%	13,768	$55,210	—	31 Mar 2023	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.02%	13,624	$55,000	—	31 Mar 2023	13F
LPL Financial LLC	13F	Company	0.02%	13,664	$54,793	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	12,087	$48,469	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	10,866	$43,000	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	8,000	$32,080	—	31 Mar 2023	13F
BANK OF MONTREAL /CAN/	13F	Company	0.02%	10,000	$29,600	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	5,033	$20,000	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0%	2,955	$11,850	—	31 Mar 2023	13F
Middle East Fze Point72	13F	Individual	0%	2,447	$9,812	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	2,163	$8,674	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0%	1,569	$6,292	—	31 Mar 2023	13F
NewEdge Advisors, LLC	13F	Company	0%	250	$1,003	—	31 Mar 2023	13F
Coston, McIsaac & Partners	13F	Company	0%	383	$1,000	—	31 Mar 2023	13F

Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q2 2023

As of 30 Jun 2023, Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,605,170 shares. The largest 10 holders included Laurion Capital Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Tekla Capital Management LLC, HHLR ADVISORS, LTD., BRIDGEWAY CAPITAL MANAGEMENT, LLC, BlackRock Inc., ExodusPoint Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 46 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.